Thymol
In clinical developmentAlso known as 5-Methyl-2-(1-Methylethyl)Phenol, IPMP, Isopropyl cresol, Listerine Antiseptic+1 more
5-Methyl-2-(1-Methylethyl)Phenol, IPMP, Isopropyl cresol, Listerine Antiseptic, Listerine Ultraclean.
Recent clinical, regulatory, research and industry developments relating to this drug.
Thymol Administration Effects on Netrin-1 Serum Concentration on Obese Patients
Thymol and Thyme Essential Oil-New Insights into Selected Therapeutic Applications.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- Molecules (Basel, Switzerland)1
- Bodalska A1
- Fecka I1
- Kowalczyk A1
- Przychodna M1
- Sopata S1
- Wroclaw Medical University1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials